nbi-98854
Showing 1 - 9 of 9
Tourette Syndrome Trial in United States (NBI-98854, Placebo)
Completed
- Tourette Syndrome
- NBI-98854
- Placebo
-
Long Beach, California
- +29 more
Apr 27, 2020
Tardive Dyskinesia Trial in Puerto Rico, United States (NBI-98854, Placebo)
Completed
- Tardive Dyskinesia
- NBI-98854
- Placebo
-
Little Rock, Arkansas
- +50 more
Oct 9, 2017
Tardive Dyskinesia Trial in Puerto Rico, United States (NBI-98854, Placebo)
Completed
- Tardive Dyskinesia
- NBI-98854
- Placebo
-
Costa Mesa, California
- +21 more
Jul 11, 2017
Tardive Dyskinesia Trial in United States (NBI-98854, Placebo)
Completed
- Tardive Dyskinesia
- NBI-98854
- Placebo
-
Little Rock, Arkansas
- +10 more
Jul 14, 2017
Tardive Dyskinesia Trial in Canada, Puerto Rico, United States (NBI-98854, Placebo)
Completed
- Tardive Dyskinesia
- NBI-98854
- Placebo
-
Little Rock, Arkansas
- +53 more
Jun 9, 2017
Tourette Syndrome Trial in United States (NBI-98854)
Completed
- Tourette Syndrome
- NBI-98854
-
San Diego, California
- +9 more
Jan 5, 2016
Tardive Dyskinesia Trial in Toronto (NBI-98854)
Completed
- Tardive Dyskinesia
- NBI-98854
-
Toronto, Ontario, Canada(unnamed)
Apr 18, 2011